Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Shares Outstanding (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Shares Outstanding data on record, last reported at $66.6 million in Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 23.4% to $66.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $66.6 million, a 23.4% increase, with the full-year FY2025 number at $66.6 million, up 23.37% from a year prior.
  • Shares Outstanding reached $66.6 million in Q1 2026 per FULC's latest filing, roughly flat from $66.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for FULC hit a ceiling of $66.6 million in Q1 2026 and a floor of $40.7 million in Q1 2022.
  • A 5-year average of $56.5 million and a median of $54.1 million in 2025 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: skyrocketed 195277066.67% in 2022, then decreased 13.13% in 2025.
  • Tracing FULC's Shares Outstanding over 5 years: stood at $52.1 million in 2022, then grew by 18.84% to $61.9 million in 2023, then decreased by 12.84% to $54.0 million in 2024, then grew by 23.37% to $66.6 million in 2025, then rose by 0.04% to $66.6 million in 2026.
  • Business Quant data shows Shares Outstanding for FULC at $66.6 million in Q1 2026, $66.6 million in Q4 2025, and $54.1 million in Q3 2025.